Correction to: Efficacy, Safety, and Tolerability of 
Omilancor in a Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Ulcerative Colitis

Saved in:
Bibliographic Details
Published in:Inflammatory bowel diseases 2022-12, Vol.28 (12), p.1938-1938
Main Authors: Leber, Andrew, Hontecillas, Raquel, Tubau-Juni, Nuria, Lichtiger, Simon, Bassaganya-Riera, Josep
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1078-0998
1536-4844
DOI:10.1093/ibd/izac055